Clinical Trial

Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 28, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
A Phase 1, Open-label Extension Groups Study in Subjects having Hepatic Impairment with Cirrhosis due to Cholestatic Liver Disease
Protocol Amendment History 3 changes
critical Primary endpoint(s) modified 2026-07-29
notable Primary completion pushed: 2026-03-31 -> 2026-07-31 2026-07-29
minor Completion pushed: 2026-03-31 -> 2026-07-31 2026-07-29
Trial Details
NCT Number NCT05045482
Lead Sponsor Zydus Therapeutics Inc.
Conditions Hepatic Impairment, Cirrhosis, Cholestatic Liver Disease
Enrollment 30 participants
Start Date 2021-10-21
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-28